About Inventys
Data last updated:
Inventys is a company based in Mumbai (India) founded in 2005 by Deepak B Birewar. It operates as a Managed Services and Direct-to-Consumer (D2C). Inventys has raised $64.34 million across 4 funding rounds from investors including Multi Organics, Plutus Wealth and India Inflection Opportunity Fund. The company has 218 employees. Inventys offers products and services including Exclusive Manufacturing, CDMO Services, and Specialty Chemicals. Inventys operates in a competitive market with competitors including Viyash, Blue Jet Healthcare, Shogun Organics, Aparna Pharmaceuticals and Ami organics, among others.
- Headquarter Mumbai, India
- Employees 218
- Founders Deepak B Birewar
- Stage Minicorn
- SectorsChemicals & MaterialsHealthcare Industrial Goods & Manufacturing
- EmailLocked
- PhoneLocked
- Website inventys.in
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Inventys Research Company
- Date of Incorporation 14 Nov, 2005
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue$6.96 M (USD)-53.61as on Mar 31, 2023
- Net Profit-$1.38 M (USD)-184.77as on Mar 31, 2023
- EBITDA$279.77 K (USD)-93.13as on Mar 31, 2023
- Total Equity Funding$64.34 M (USD)
in 4 rounds
- Latest Funding Round$29.49 M (USD), Series B
Apr 20, 2022
- InvestorsMulti Organics
& 9 more
- Employee Count218
Associated legal entities of Inventys
Inventys operates through Inventys Research Company Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Report |
|---|---|---|---|---|---|---|---|
| Inventys Research Company Private Limited CIN U74210MH2005PTC157304 | Active | 14 Nov 2005 | Mumbai, Maharashtra | ₹101 Cr | 218 | 4 | Buy report |
People of Inventys
3 people are tracked at Inventys (3 in leadership); the tracked headcount is 218.
| Name | Role | Group |
|---|---|---|
| Founder & Managing Director | Leadership | |
| Director | Leadership | |
| Chairman & Managing Director | Leadership |
Complete people profiles for Inventys
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Board of directors of Inventys Research Company Private Limited (Inventys)
Inventys Research Company Private Limited is the primary company behind Inventys. The board of Inventys Research Company Private Limited currently have 4 directors; the longest-serving is Deepak Baburao Birewar, appointed in 2005. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Deepak Baburao Birewar DIN 00023388 | Managing Director | 14 Nov 2005 | 20 yrs 10 mo | Inventys Research Company Private Limited |
| Umesh Jagannath Kamat DIN 00348735 | Whole-time director | 11 Apr 2019 | 7 yrs 5 mo | Inventys Research Company Private Limited |
| Rushikesh Deepak Birewar DIN 09536286 | Whole-time director | 14 Mar 2022 | 4 yrs 6 mo | Inventys Research Company Private Limited |
| Ganesh Anant Nigudkar DIN 10759034 | Director | 29 Aug 2024 | 2 yrs 1 mo | Inventys Research Company Private Limited |
Products & Services of Inventys
Inventys offers a comprehensive portfolio of products and services, including Exclusive Manufacturing, CDMO Services, and Specialty Chemicals.
Exclusive chemical manufacturing is provided for unique customer needs.
CDMO services are offered for life sciences molecule advancement.
Specialty chemicals are produced for pharma and electronics industries.
Financials of Inventys
Figures of Inventys Research Company Private Limited, the primary company behind Inventys, for FY 2026. Revenue was ₹101 Cr (+184% year on year). Net profit was ₹5.43 Cr (5% margin). EBITDA was ₹26.29 Cr (26% margin). Revenue has grown at a compounded annual rate of +20% over three years and -4% over five years.
- ₹101 CrRevenue · FY 2026 · +184% YoY
- ₹5.43 CrNet profit · 5% margin
- ₹26.29 CrEBITDA · 26% margin
- ₹0.60 CrPaid-up capital
- 218Employees (provident fund records)
- +20%Revenue CAGR, 3 years
- -4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Inventys Research Company Private Limited are on its company page.
Buy the company report of Inventys Research Company Private LimitedDetailed financial statements for Inventys
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Funding Insights of Inventys
Inventys has successfully raised a total of $64.34M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $29.49 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $64.3M
- Total Rounds 4
- Last Round Series B — $29.5M
- First Round $810,467
(15 Dec 2007)
- Investors Count 10
All 4 funding rounds of Inventys with amounts, post-money valuations and investors.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| 20 Apr 2022 | $29.5M | Series B | – | Plutus Wealth Management , Pantomath Group | – |
| 12 Apr 2022 | $34.0M | Angel Round | $249.6M | Arpit Khandelwal , Arpit Khandelwal | – |
| 15 Dec 2008 | $43,550 | Seed | – | – | |
| 15 Dec 2007 | $810,467 | Seed | $1.8M | Multi Organics |
| Date | Stage | Valuation |
|---|---|---|
| 12 Apr 2022 | Minicorn | $249.6M |
| 15 Dec 2007 | Minicorn | $1.8M |
Last known valuation $249.6M (Apr 2022). Current stage: Minicorn. 10 investors in total: 3 institutional and 7 angel.
Investors in Inventys
Inventys has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Multi Organics, Plutus Wealth and India Inflection Opportunity Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed across multiple sectors. | – | plutuswealth.in | Ahmedabad, India | |
Investment services are provided to emerging pre-IPO enterprises. | – | pantomathamc.com | Mumbai, India | |
Leading manufacturer of speciality chemicals and advanced intermediates with global reach. | 1976 | multiorganics.com | Mumbai, India | |
AK Arpit Khandelwal | Angel investor and entrepreneur, focused on tech startups in India. | – | unknown_3d85f218c62c486c8 | - |
AK Arpit Khandelwal | - | – | unknown_860e94b054c941dd9 | - |
NN Neeta Naik | - | – | unknown_23d5fb87c6de4c6a9 | - |
SB Shobana Birewar | - | – | unknown_9962615db4344cc6b | - |
AB Abhijeet Birewar | Angel investor and entrepreneur, focused on tech startups, based in India. | – | unknown_c8e5555492564846b | - |
BV Baburao V Birewar | - | – | unknown_2299953ad7224f5ab | - |
AB Alka Birewar | - | – | unknown_4ef4fcb21e774adab | - |
Investor details for Inventys
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Inventys
4 dated milestones of Inventys across 17 years, from founding to its latest funding, stage changes and deals.
- Inventys is founded.
- First funding round of $810K.
- Reaches Minicorn status.
- Latest funding round, Series B, of $29.5M.
Competitors of Inventys
Inventys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Blue Jet Healthcare, Shogun Organics, Aparna Pharmaceuticals and Ami organics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.0M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| bluejethealthcare.com | 1969 | Mumbai, India | – | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs | |
| shogunorganics.com | 2002 | Mumbai, India | – | 1,977 | Contract manufacturer of chemicals used in household insecticide products | |
| aparnapharma.com | 2008 | Hyderabad, India | $674,328 | 328 | API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | |
| amiorganics.com | 2007 | Surat, India | – | 4 | Advanced API intermediates are manufactured for pharmaceutical use. | |
| evexialifecare.com | 1990 | Vadodara, India | – | 23 | Contract manufacturer of pharma chemicals | |
| alkylamines.com | 1979 | Navi Mumbai, India | – | 688 | Aliphatic amines, derivatives, and specialty amines are supplied to industries. |
Detailed competitors of Inventys
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inventys
Complete news archive for Inventys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Inventys
Inventys was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Inventys is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Inventys is a funded company, having raised a total of $64.34M across 4 funding rounds to date. The company's 1st funding round was a Seed of $810.47K, raised on Dec 15, 2007.
Inventys has 218 employees.
Annual revenue of Inventys is $6.96M as on Mar 31, 2023.
Inventys Research Company is engaged in providing exclusive manufacturing and CDMO services to innovators in life sciences, focusing on crop protection, pharmaceuticals, and specialty chemicals. Operations are supported by expertise in flow chemistry, green chemistry, and deep backward integration. Services are extended across sectors like healthcare and electronics with a commitment to sustainability and innovation. Manufacturing capacities are being expanded to position Inventys among Indias top specialty chemical producers.
Inventys's top competitors include Viyash, Shogun Organics and Blue Jet Healthcare.
Inventys offers Exclusive Manufacturing, CDMO Services, and Specialty Chemicals.
Inventys has 10 investors. Key investors include Multi Organics, Plutus Wealth, India Inflection Opportunity Fund, Arpit Khandelwal, and Arpit Khandelwal.
The valuation of Inventys is $249.61M as of Apr 2022.
Inventys operates through Inventys Research Company Private Limited.
Inventys is classified as a minicorn.
The legal entities of Inventys currently have 4 directors, including Umesh Jagannath Kamat, Deepak Baburao Birewar, Rushikesh Deepak Birewar and others.